NCT03924518View on ClinicalTrials.gov

Adjunctive Granisetron Therapy in Patients With Sepsis or Septic Shock

PHASE2CompletedINTERVENTIONAL
Enrollment

154

Participants

Timeline

Start Date

April 25, 2019

Primary Completion Date

November 28, 2020

Study Completion Date

December 28, 2020

Conditions
Sepsis
Interventions
DRUG

Granisetron Hydrochloride

Granisetron will be diluted with 0.9% saline to ensure that the therapeutic drug and placebo are identical in appearance, and 50 ml syringes will serve as the containers for all intravenous drugs.

DRUG

Placebo（Normal saline）

therapeutic drug and placebo are identical in appearance, and 50 ml syringes will serve as the containers for all intravenous drugs.

Trial Locations (1)

510282

Department of Critical Care Medicine of Zhujiang Hospital,Southern Medical University, Guangzhou

All Listed Sponsors
lead

Zhujiang Hospital

OTHER

NCT03924518 - Adjunctive Granisetron Therapy in Patients With Sepsis or Septic Shock | Biotech Hunter | Biotech Hunter